Omicron News and Research

RSS

Exploring the comparative efficacy of booster vaccines against SARS-CoV-2 Omicron and Delta variants

In a new study, researchers assessed the effectiveness of SARS-CoV-2 Omicron and Delta variants.

4 Feb 2022

A disabled activist speaks out about feeling ‘disposable’

In early January, one of the country's top public health officials went on national television and delivered what she called "really encouraging news" on covid-19: A recent study showed that more than three-fourths of fatalities from the omicron variant of the virus occurred among people with several other medical conditions.

4 Feb 2022

Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2

In a new study, researchers showed that 425 nm blue light can inactivate all major SARS CoV 2 variants.

4 Feb 2022

Predicting immunity evasion of SARS-CoV-2 Omicron variant of concern

In a new study, a team of researchers assessed the affinity of the SARS-CoV-2 Omicron variant of concern towards major histocompatibility complex (MHC) binding

4 Feb 2022

Molecular simulations provide insight into SARS-CoV-2 variant RBD interactions with ACE2 and mAbs

Researchers aimed to understand the relationship between the SARS-CoV-2 receptor-binding domain and both human receptors and therapeutic targets.

3 Feb 2022

Review confirms reduced severity of SARS-CoV-2 Omicron infection

Researchers review existing literature to quantify the transmissibility, immune evasion, reinfection, and severity of the SARS-CoV-2 Omicron variant.

3 Feb 2022

Evaluating effects of D614G and P681R/H mutations on SARS-CoV-2 VOCs

Researchers evaluate how the D614G and P681H mutations alter the attributes of SARS-CoV-2 VOCs.

3 Feb 2022

Smartphone system sends COVID-19 exposure alerts to users in Missouri

Smartphones can help alert you if you've been exposed to someone with COVID-19. Washington University in St. Louis is expanding access to MO/Notify, a smartphone system that privately sends pop-up alerts to users in Missouri when they have spent time near someone who later tests positive for COVID-19.

3 Feb 2022

Global efforts to track COVID-19 variants grossly underreported a probable variant of concern in Nigeria

If the United States ignores COVID-19 in Nigeria, we forgo global genomic surveillance at our own peril, reports a new Northwestern Medicine study published in Nature Communications.

3 Feb 2022

Neutralizing antibodies against SARS-CoV-2 variants induced by homologous and heterologous COVID-19 booster vaccination

In this study, scientists focused on identifying tentative cut-offs for large-scale evaluations of immune protection against SARS-CoV-2 and its variants.

3 Feb 2022

Study finds pediatric acute upper airway infection cases have increased during the Omicron variant surge

Researchers conducted a retrospective cohort study to determine if pediatric acute upper airway infection was more common during the surge of the Omicron strain of SARS-CoV-2 in the US.

3 Feb 2022

Nanoparticle vaccine effective against eight SARS-CoV-2 variants in non-human primates

Researchers demonstrate that SARS-CoV-2 RBD-based nanoparticle vaccine induces neutralizing antibodies against SARS-CoV-2 variants.

2 Feb 2022

Antigenic map of SARS-CoV-2 variants reveals amino acid substitutions that govern immune escape and immunodominance

Researchers use antigenic cartography to analyze cross-reactivity patterns of eight groups of human sera on a panel of SARS-CoV-2 variants.

2 Feb 2022

Analysis of SARS-CoV-2 Omicron variant-associated travel restrictions worldwide

Researchers evaluate the travel restrictions placed by nations worldwide following the emergence of the SARS-CoV-2 Omicron variant.

2 Feb 2022

Omicron variant's 'milder' outcomes may be due to more population immunity

The SARS-CoV-2 Omicron variant's "milder" outcomes are likely due to more population immunity compared to earlier waves of the pandemic rather than the virus's properties, according to a paper by William Hanage, associate professor of epidemiology and co-director of the Center for Communicable Disease Dynamics at Harvard T.H. Chan School of Public Health, and Roby Bhattacharyya, assistant professor at Massachusetts General Hospital and Harvard Medical School and associate member at the Broad Institute of MIT and Harvard.

2 Feb 2022

Omicron News and Research

Exploring the comparative efficacy of booster vaccines against SARS-CoV-2 Omicron and Delta variants

A disabled activist speaks out about feeling ‘disposable’

Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2

Predicting immunity evasion of SARS-CoV-2 Omicron variant of concern

Molecular simulations provide insight into SARS-CoV-2 variant RBD interactions with ACE2 and mAbs

Review confirms reduced severity of SARS-CoV-2 Omicron infection

Evaluating effects of D614G and P681R/H mutations on SARS-CoV-2 VOCs

Smartphone system sends COVID-19 exposure alerts to users in Missouri

Global efforts to track COVID-19 variants grossly underreported a probable variant of concern in Nigeria

Neutralizing antibodies against SARS-CoV-2 variants induced by homologous and heterologous COVID-19 booster vaccination

Study finds pediatric acute upper airway infection cases have increased during the Omicron variant surge

Nanoparticle vaccine effective against eight SARS-CoV-2 variants in non-human primates

Antigenic map of SARS-CoV-2 variants reveals amino acid substitutions that govern immune escape and immunodominance

Analysis of SARS-CoV-2 Omicron variant-associated travel restrictions worldwide

Omicron variant's 'milder' outcomes may be due to more population immunity

Booster dose of Covaxin vaccine candidate neutralizes Omicron and Delta variants

UK's world-leading human challenge study provides new insights into mild SARS-CoV-2 infections

Exploring protection via a 4th dose of BNT162b2 against SARS-CoV-2 Omicron variant in Israel

SARS-CoV-2 omicron variant shown to replicate less efficiently in human lungs

N gene target failure method effectively detects SARS-CoV-2 Omicron in clinical samples

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News